Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Alexion Pharmaceuticals, Inc.    ALXN   US0153511094

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/17/2014 07/18/2014 07/21/2014 07/22/2014 07/23/2014 Date
155.06(c) 161.25(c) 163.37(c) 167.97(c) 173.08(c) Last
1 557 152 1 083 771 1 048 533 1 588 628 1 747 340 Volume
-2.34% +3.99% +1.31% +2.82% +3.04% Change
More quotes
Company
Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, engages in the innovation, development, and commercialization of life-transforming therapeutic products for treating patients with severe and ultra-rare disorders. It focuses on developing products for the treatment of diseases in the... 
Sector
Pharmaceuticals
Calendar
07/24Earnings Release
Surperformance© rating of Alexion Pharmaceuticals, I
Trading Rating : Investor Rating :
More about the company
Chart ALEXION PHARMACEUTICALS, I
Duration : Period :
Alexion Pharmaceuticals, I Technical Analysis Chart | ALXN | US0153511094 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 2 183 M
EBIT 2014 1 080 M
Net income 2014 677 M
Finance 2014 1 783 M
Yield 2014 -
Sales 2015 2 651 M
EBIT 2015 1 305 M
Net income 2015 918 M
Finance 2015 2 895 M
Yield 2015 -
PER 2014 51,90
PER 2015 36,43
EV / Sales 2014 14,0x
EV / Sales 2015 11,1x
Capitalization 32 314 M
More Financials
Latest news on ALEXION PHARMACEUTICALS, I
1d ago NASDAQ 100 MOVERS : Nflx, wynn
07/16 ALEXION PHARMACEUTICALS : to Report Second Quarter 2014 Results on Thursday, Jul..
07/16 ALEXION PHARMACEUTICALS : Change in Directors or Principal Officers, Financial S..
07/16 ALEXION PHARMACEUTICALS : Announces the Appointments of David R. Brennan, M. Mic..
07/10 ALEXION PHARMACEUTICALS : to Report Second Quarter 2014 Results on Thursday, Jul..
07/09 S&P 500 MOVERS : Grmn, aa
06/28 ALEXION PHARMACEUTICALS : and Cincinnati Children's Hospital Establish Rare Dise..
06/28 ALEXION PHARMACEUTICALS : Secures FDA Orphan Drug Designation for Soliris (eculi..
06/26 U.S. healthcare profit outlook brightens on Obamacare, drug prices
06/26 ALEXION PHARMACEUTICALS : and Cincinnati Children's Hospital Establish Rare Dise..
06/25 ALEXION PHARMACEUTICALS : FDA Grants Orphan Drug Designation to Soliris® eculizu..
06/24 ALEXION PHARMACEUTICALS : Gets FDA Orphan Drug Designation for Soliris (eculizum..
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Technical analysis
Income Statement Evolution
Alexion Pharmaceuticals, I : Income Statement Evolution
More Financials
EPS Revisions
Alexion Pharmaceuticals, I : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF